Dr. Lalezari will be joined at the conference by Dr. Richard Pestell, MD, PhD, AO, Lead Consultant in Preclinical and Clinical Oncology, who will present during the poster display session in Hall B0 ...

ImmunityBio, Inc. faces stock decline amid fundraising and market selloff. Click to read more on the long-term potential of ...

A research team at the Technical University of Munich (TUM) has developed a method to predict early-stage kidney damage caused by certain cancer treatments. The kidneys begin to shrink slightly—months ...

Three abstracts were presented from Photocure's U.S. Blue Light Cystoscopy with Cysview Registry, a large multicenter bladder cancer patient registry of real-world data, established by Photocure in ...

This exclusive private label distribution agreement with Smith+Nephew is a significant development for Nuo ,” commented David Jorden, Nuo’s Chief Executive and Financial Officer. “ We could not ...

Discover how African American families are navigating asthma care amid alarming health disparities, with actionable ...

Persistent exhaustion affects 1 in 4 Americans, yet many struggle for years without diagnosis. Discover the overlooked causes ...

Q1 2025 Earnings Call Transcript April 24, 2025 Gentherm Incorporated beats earnings expectations. Reported EPS is $0.51, ...

Dental education has experienced unprecedented transformation, driven by the demand to enhance oral health care delivery ...

One of the most troubling realities of our time is organised crime. Numerous criminal web networks have spread internationally, hiding under facades of clean businesses and charity projects, yet ...

Commercial Progress: The first full quarter of Attruby net product revenue was $36.7 million. As of April 25, 2025, 2,072 unique patient prescriptions for Attruby have been written by 756 unique ...

If you've ever tried to build a new habit—whether that's exercising more, eating healthier, or going to bed earlier—you may ...